Cresco Labs (OTC: CRLBF)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-10 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | |||||||
REV | 218.440M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cresco Labs (OTCQX: CRLBF) through any online brokerage.
There are no as such competitors for Cresco Labs.
The latest price target for Cresco Labs (OTCQX: CRLBF) was reported by Piper Sandler on Thursday, August 18, 2022. The analyst firm set a price target for 6.00 expecting CRLBF to rise to within 12 months (a possible 56.25% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Cresco Labs (OTCQX: CRLBF) is $3.84 last updated August 24, 2022, 7:58 PM UTC.
There are no upcoming dividends for Cresco Labs.
Cresco Labs’s Q3 earnings are confirmed for Thursday, November 10, 2022.
There is no upcoming split for Cresco Labs.
Cresco Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.